Greyson International, Inc. Receives Notice of Allowance from the U.S. Patent and Trademark Office for its Breakthrough Trilexon® Delivery System Technology

Coconut Creek, Fla. – July 23, 2012 – Greyson International, Inc. (GYSN.PK) announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office, which means that it’s patent application, has been approved for the breakthrough technology. The awarding of this patent culminates over five years of effort in pursuing a U.S. patent covering this revolutionary “DELIVERY SYSTEM”.

Trilexon® Delivery System Technology, allows active ingredients to work for a longer period of time than other products currently available on the market, and therefore produces results never before possible. The Trilexon® delivery system can improve the effectiveness of virtually every topical application in almost any field imaginable.

Greyson International CEO, Harvey Tauman, said that “The US Patent and Trademark Office’s Notice of Allowance further confirms that Trilexon® is a revolutionary breakthrough with capabilities that were never possible before. This protects this unique and momentous discovery as intellectual property for Greyson.  We are very confident that this patent will support us in moving forward with marketing and licensing agreements wherever active ingredients are needed. This trans-dermal delivery system could be used more effectively in cosmetic, medical and veterinary use.”

It has been reported that only about 5% of all cosmetics on the market today are patented.” Greyson originally applied for this on September 28, 2009. This puts Greyson’s Trilexon® patent in force until September 28, 2029. The new, allowed patent application is for a “Utility” patent and, according to the US Patent Office, a utility patent is only obtained when the invention is for a “new and useful process, machine, manufacture, or composition of matter.”

About Greyson International, Inc.

Greyson International, Inc. is a research, development and marketing company that markets health and beauty aid products. Trilexon® is a registered trademark of Greyson International. For more information, visit; join the Greyson Facebook group page by visiting

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.


Harvey Tauman

Greyson International Inc.

Chief Executive Officer

(954) 482-0497

† Trilexon® is a registered trademark of Greyson International, Inc.

Recommended Posts